Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Natera Inc (NTRA)

Natera Inc (NTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,481,020
  • Shares Outstanding, K 141,731
  • Annual Sales, $ 2,306 M
  • Annual Income, $ -208,160 K
  • EBIT $ -308 M
  • EBITDA $ -265 M
  • 60-Month Beta 1.65
  • Price/Sales 11.23
  • Price/Cash Flow N/A
  • Price/Book 15.84

Options Overview Details

View History
  • Implied Volatility 57.48% (-1.25%)
  • Historical Volatility 44.22%
  • IV Percentile 80%
  • IV Rank 46.01%
  • IV High 86.29% on 04/08/25
  • IV Low 32.92% on 06/16/25
  • Expected Move (DTE 17) 14.90 (7.98%)
  • Put/Call Vol Ratio 1.02
  • Today's Volume 83
  • Volume Avg (30-Day) 590
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 16,823
  • Open Int (30-Day) 20,838
  • Expected Range 171.94 to 201.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.55
  • Number of Estimates 5
  • High Estimate -0.41
  • Low Estimate -0.65
  • Prior Year -0.50
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.00 +6.96%
on 03/27/26
210.51 -8.03%
on 03/03/26
-14.44 (-6.94%)
since 02/27/26
3-Month
181.00 +6.96%
on 03/27/26
256.36 -24.48%
on 01/07/26
-40.14 (-17.17%)
since 12/26/25
52-Week
125.38 +54.41%
on 04/07/25
256.36 -24.48%
on 01/07/26
+49.66 (+34.50%)
since 03/28/25

Most Recent Stories

More News
SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery

Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free

NTRA : 193.60 (+3.62%)
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

FTRE : 8.97 (+1.13%)
NTRA : 193.60 (+3.62%)
ELAN : 23.76 (+1.37%)
TNDM : 20.00 (+2.12%)
MYGN : 4.34 (-0.46%)
1 Unprofitable Stock to Own for Decades and 2 Facing Headwinds

1 Unprofitable Stock to Own for Decades and 2 Facing Headwinds

NTRA : 193.60 (+3.62%)
HNST : 2.90 (+0.35%)
CSGP : 41.30 (+1.03%)
1 Cash-Heavy Stock to Target This Week and 2 We Question

1 Cash-Heavy Stock to Target This Week and 2 We Question

NTRA : 193.60 (+3.62%)
RGEN : 111.49 (+1.24%)
REAX : 2.46 (+2.07%)
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

NTRA : 193.60 (+3.62%)
NEO : 7.20 (unch)
AMPH : 19.41 (+0.99%)
Two Publications Highlight Clinical Utility of Signatera™ in Anal and Rectal Cancers

New findings show that Signatera status can help identify high-risk patients and inform non-operative management and surveillance strategies

NTRA : 193.60 (+3.62%)
3 Growth Stocks to Add to Your Roster

3 Growth Stocks to Add to Your Roster

NTRA : 193.60 (+3.62%)
FSS : 104.77 (-1.60%)
TOST : 26.55 (+1.88%)
3 Market-Beating Stocks to Target This Week

3 Market-Beating Stocks to Target This Week

NTRA : 193.60 (+3.62%)
BLBD : 54.42 (-1.25%)
ULS : 82.20 (-2.04%)
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026

MENLO PARK, Calif. , March 12, 2026 /PRNewswire/ -- MyOme, a leader in clinical whole-genome analysis, announced an advancement in rare disease diagnostics at the American College of Medical Genetics...

NTRA : 193.60 (+3.62%)
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis

New genomic testing solution designed to shorten diagnostic journeys for patients and families; supports efforts to reduce the economic and societal burden of rare diseases...

NTRA : 193.60 (+3.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 194.25
2nd Resistance Point 190.63
1st Resistance Point 188.73
Last Price 193.60
1st Support Level 183.21
2nd Support Level 179.59
3rd Support Level 177.69

See More

52-Week High 256.36
Fibonacci 61.8% 206.33
Last Price 193.60
Fibonacci 50% 190.87
Fibonacci 38.2% 175.41
52-Week Low 125.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.